ERYP - Erytech Pharma - ADR
Close
0.79
-0.030 -3.797%
Share volume: 0
Last Updated: Thu 29 Jun 2023 10:00:00 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$0.82
-0.03
-3.66%
Summary score
76%
Profitability
93%
Dept financing
25%
Liquidity
0%
Performance
90%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ERYP | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | 0% | -4.61% | -11.83% | 0% |
| Return on assets | 0% | -4.6% | -10.3% | 0% |
| Return on sales | 0% | -37.29% | 0% | 0% |
| Return on invested capital | 0% | 265.33% | -27.14% | 0% |
| Profitability | 75% | 25% | 0% | 0% |
| Total debt ratio | 0% | 18.22% | 14.3% | 0% |
| Debt ratio change over time | 0% | -1.66% | -1.56% | 0% |
| Dept financing | 25% | 25% | 20% | 0% |
| Current Ratio | 0% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 0% | 0.81% | 2.5% | 0% |
| Liquididy | 0% | 53% | 50% | 0% |
| Short-term ratios | ERYP | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | 0% | -3.62% | -13.55% | 0% |
| Return on assets | 0% | -3.93% | -11.56% | 0% |
| Return on sales | 0% | -34.27% | 0% | 0% |
| Return on invested capital | 0% | -9.88% | -24.84% | 0% |
| Profitability | 100% | 0% | 0% | 0% |
| Total debt ratio | 0% | 15.47% | 15.89% | 0% |
| Debt ratio change over time | 0% | -0.59% | -1.72% | 0% |
| Dept financing | 25% | 24% | 25% | 0% |
| Current Ratio | 0% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 0% | 0.81% | 2.5% | 0% |
| Liquididy | 0% | 56% | 50% | 0% |